(Q35861879)

10 August 2017

Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z. (English)

1 reference

10 August 2017

R H Hunt

1

1 reference

10 August 2017

D Armstrong

2

1 reference

10 August 2017

M Yaghoobi

3

1 reference

10 August 2017

C James

4

1 reference

10 August 2017

Y Chen

5

1 reference

10 August 2017

J Leonard

6

1 reference

10 August 2017

J M Shin

7

1 reference

10 August 2017

E Lee

8

1 reference

10 August 2017

D Tang-Liu

9

1 reference

10 August 2017

G Sachs

10

1 reference

10 August 2017

language of work or name

English

0 references

publication date

25 April 2008

1 reference

Alimentary Pharmacology & Therapeutics

10 August 2017

1 reference

10 August 2017

28

1 reference

10 August 2017

2

1 reference

10 August 2017

187-199

1 reference

Taste receptors in the gastrointestinal tract. V. Acid sensing in the gastrointestinal tract

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Review article: the clinical pharmacology of proton pump inhibitors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Effectiveness of proton pump inhibitors in nonerosive reflux disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Pepsins and the mucus barrier in peptic ulcer disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Progress with proton pump inhibition

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Effect on intragastric pH of a PPI with a prolonged plasma half-life: comparison between tenatoprazole and esomeprazole on the duration of acid suppression in healthy male volunteers

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4505925

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18445141

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Integrated acidity and the pathophysiology of gastroesophageal reflux disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18445141

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18445141

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2036.2008.03725.X

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

18445141

1 reference